ArticleInternal medicine (Tokyo, Japan)2022

Successful Control of Hypercalcemia with Sorafenib, Evocalcet, and Denosumab Combination Therapy for Recurrent Parathyroid Carcinoma.

Hirofumi Makino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.